Superior cancer therapeutics using transformative innovations
Safer with less side effects for patients
Next-generation ADCs and novel antibody formats will take safety to the next level
Building a unique pipeline
With a strong foundation in ADCs and our lead program in clinical studies in AML
A team pushing the boundaries
The VERAXA team is constantly evolving its technology suite to build better and safer medicines
learn more